HeraMED Limited (ASX:HMD)

Australia · Delayed Price · Currency is AUD

0.0350

-0.0010 (-2.78%)

Aug 28, 2026, 3:40 PM AEST

6.06% (1Y)

Market Cap	40.51M +25.5%
Revenue (ttm)	330.44K -10.3%
Net Income	-3.47M
EPS	-0.00
Shares Out	1.16B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	237,044
Open	0.0370
Previous Close	0.0360
Day's Range	0.0350 - 0.0370
52-Week Range	0.0300 - 0.0550
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 3, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2011

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol HMD

Full Company Profile

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.

Financial Statements